Repare Therapeutics Inc. (RPTX) Misses Q4 EPS by 5c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q4 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $9.72 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c